These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 205342)

  • 1. Abrogation of tumor rejection by trypan blue.
    Kreider JW; Bartlett GL; DeFreitas E
    Cancer Res; 1978 Apr; 38(4):1036-40. PubMed ID: 205342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of activated macrophages in nonspecific resistance to neoplasia.
    Hibbs JB
    J Reticuloendothel Soc; 1976 Sep; 20(3):223-31. PubMed ID: 789879
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of immunological eradication of a syngeneic guinea pig tumor: participation of a component(s) of recipient origin in the expression of systemic adoptive immunity.
    Shu S; Fonseca LS; Kato H; Zbar B
    Cancer Res; 1983 Jun; 43(6):2637-43. PubMed ID: 6342756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of cellular immunity to tumor antigens of a guinea pig hepatoma by inhibition of macrophage migration.
    Churchill WH; Zbar B; Belli JA; David JR
    J Natl Cancer Inst; 1972 Feb; 48(2):541-9. PubMed ID: 4119886
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum factors that inhibit in vitro immunological reactions in malignant tumor development in experimental animals].
    Lomakin MS; Larin AS; Mamaeva TN; Levitina VL
    Vopr Onkol; 1977; 23(10):76-82. PubMed ID: 202095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma.
    Bast RC; Zbar B; Miller TE; Mackaness GB; Rapp HJ
    J Natl Cancer Inst; 1975 Mar; 54(3):757-61. PubMed ID: 164568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM; Whitten HD; Lewis GK; Watson ES
    Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of the immune response of newborn and adult animals to the administration of tumor extracts].
    Nikonova MF; Maĭskiĭ IN; Pokrovskaia TA
    Biull Eksp Biol Med; 1975 Jun; 79(6):85-8. PubMed ID: 177126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of cell-mediated tumor cell lysis and complement-induced cytotoxicity by trypan blue.
    Scornik JC; Ruiz P; Hoffman EM
    J Immunol; 1979 Sep; 123(3):1278-84. PubMed ID: 469250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of trypan blue treatment on the immune responses of mice.
    Kripke ML; Norbury KC; Gruys E; Hibbs JB
    Infect Immun; 1977 Jul; 17(1):121-9. PubMed ID: 18403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific tumor immunity induced with mitomycin C-treated syngeneic tumor cells (MCT). Effects of carrageenan and trypan blue on MCT-induced immunity in mice.
    Wu RL; Kearney R
    J Natl Cancer Inst; 1980 Jan; 64(1):81-7. PubMed ID: 6928050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

  • 13. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors.
    Chapes SK; Gooding LR
    J Immunol; 1985 Sep; 135(3):2192-8. PubMed ID: 2991384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased binding and killing of neuraminidase-galactose oxidase-treated tumor cells by normal macrophages.
    Piessens WF
    J Immunol; 1977 Jul; 119(1):167-72. PubMed ID: 194981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
    Bucana C; Hoyer LC; Hobbs B; Breesman S; McDaniel M; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4444-58. PubMed ID: 187323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG.
    Harmel RP; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Feb; 54(2):515-7. PubMed ID: 234537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte cytotoxicity: evidence for multiple mechanisms of in vitro erythrocyte target killing. Trypan blue can both inhibit and enhance target lysis.
    Hall RE; Muchmore AV; Blaese RM
    J Reticuloendothel Soc; 1982 Sep; 32(3):233-46. PubMed ID: 7153988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of tumor-specific delayed hypersensitivity in vitro to normal guinea pig peritoneal exudate cells using RNA extracts from sensitized lymphoid tissues.
    Paque RE; Meltzer MS; Zbar B; Rapp HJ; Dray S
    Cancer Res; 1973 Dec; 33(12):3165-71. PubMed ID: 4357351
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
    Jessup JM; Riggs CW; Hanna MG
    Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.